Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer-Reference-Cited by-同舟云学术

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer

Published:2014-01-30 Issue:1 Volume:7 Page:
ISSN:1755-8794
Container-title:BMC Medical Genomics
language:en
Short-container-title:BMC Med Genomics

Author:

Koestler Devin C,Chalise Prabhakar,Cicek Mine S,Cunningham Julie M,Armasu Sebastian,Larson Melissa C,Chien Jeremy,Block Matthew,Kalli Kimberly R,Sellers Thomas A,Fridley Brooke L,Goode Ellen L

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1186/1755-8794-7-8.pdf

Reference76 articles.

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 2013, 63 (1): 11-30. 10.3322/caac.21166.

2. Bodurka-Bevers D, Sun CC, Gershenson DM: Pharmacoeconomic considerations in treating ovarian cancer. Pharmacoeconomics. 2000, 17 (2): 133-150. 10.2165/00019053-200017020-00003.

3. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011, 103 (2): 117-128. 10.1093/jnci/djq495.

4. Cicek MS, Koestler DC, Fridley BL, Kalli KR, Armasu SM, Larson MC, Wang C, Winham SJ, Vierkant RA, Rider DN, et al: Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K + channel. Hum Mol Genet. 2013, 22 (15): 3038-3047. 10.1093/hmg/ddt160.

5. Bauerschlag DO, Ammerpohl O, Brautigam K, Schem C, Lin Q, Weigel MT, Hilpert F, Arnold N, Maass N, Meinhold-Heerlein I, et al: Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles. Oncology. 2011, 80 (1–2): 12-20.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The DNA methylome of cervical cells can predict the presence of ovarian cancer;Nature Communications;2022-02-01

2. The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort;PLOS ONE;2021-08-27

3. DNA Methylation in Ovarian Cancer Susceptibility;Cancers;2020-12-31

4. Gene-based mediation analysis in epigenetic studies;Briefings in Bioinformatics;2020-07-01

5. CBS gene polymorphism and promoter methylation‐mediating effects on the efficacy of folate therapy in patients with hyperhomocysteinemia;The Journal of Gene Medicine;2020-04